Host: |
Goat |
Applications: |
Pep-ELISA |
Reactivity: |
Human/Dog |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-KF1/ZFP103 (C-Term) is suitable for use in ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
Peptide ELISA: antibody detection limit dilution 1:8000.WB: Approx. 35kDa and 60kDa bands observed in Human Brain and Human Liver lysates at 1ug of primary. Please note that the band we observe is different from the predicted size of approx. 79k |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
RNF103 |
Gene ID: |
7844 |
Uniprot ID: |
RN103_HUMAN |
Immunogen Region: |
C-Term |
Accession Number: |
NP_005658.1 |
Immunogen Sequence: |
YAQHQPLSNDVPS |
Function | Acts as an E2-dependent E3 ubiquitin-protein ligase, probably involved in the ER-associated protein degradation pathway. |
Protein Name | E3 Ubiquitin-Protein Ligase Rnf103Kf-1Hkf-1Ring Finger Protein 103Ring-Type E3 Ubiquitin Transferase Rnf103Zinc Finger Protein 103 HomologZfp-103 |
Database Links | Reactome: R-HSA-901032 |
Cellular Localisation | Endoplasmic Reticulum MembraneMulti-Pass Membrane Protein |
Alternative Antibody Names | Anti-E3 Ubiquitin-Protein Ligase Rnf103 antibodyAnti-Kf-1 antibodyAnti-Hkf-1 antibodyAnti-Ring Finger Protein 103 antibodyAnti-Ring-Type E3 Ubiquitin Transferase Rnf103 antibodyAnti-Zinc Finger Protein 103 Homolog antibodyAnti-Zfp-103 antibodyAnti-RNF103 antibodyAnti-ZFP103 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance